Internet-Based Drug Prevention Education for College Students
大学生网络毒品预防教育
基本信息
- 批准号:7053553
- 负责人:
- 金额:$ 46.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-08-05 至 2008-02-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): This application proposes development and testing of an interactive, online drug use prevention program for college students, MyStudentBody-Drugs (MSB-Drugs). Geared toward primary and secondary prevention, MSB-Drugs will promote motivation to prevention initiation of, or reduce, drug use and associated risk behaviors. Compared to alcohol, drug use prevention is neglected on campuses, despite the prevalence of use and significant consequences. Marijuana is the most widely used illicit drug, followed by non-medical use of prescription drugs, including stimulants (dextroamphetamine, methyphenidate) and opioids (oxycodone, hydrocodone). In 2003, roughly 10 percent of high school seniors reported non- medical use of hydrocodone, making it the third most abused substance for this group, after marijuana and amphetamines. From 2002 to 2003, abuse of oxycodone increased by nearly 40 percent among college- aged youth. Mixing prescription drugs with other drugs, such as alcohol, further increases risk for drug interactions and overdose. The public health need for easily accessible and effective drug prevention for college students is clear. Recent NIDA initiatives recognize this need (Prescription Drug Abuse, PA-01-110; Volkow, 2005). MSB-Drugs will use technology and rich media to incorporate key evidence-based prevention features, including personal risk assessments with tailored feedback to promote motivation, relevant education about different drugs and addiction to foster accurate risk appraisals, and skill-building activities to promote refusal and coping skills and self-efficacy. Phase I involved proof of concept research to demonstrate product feasibility. Phase II will involve production and usability testing of a fully operational MSB-Drugs website, and a randomized, controlled trial to assess program efficacy for influencing drug- related knowledge, attitudes, and behaviors.
描述(由申请人提供):该申请提议为大学生开发和测试一个交互式在线吸毒预防计划MyStudentBody-Drugs(MSB-Drugs)。面向初级和二级预防,MSB药物将促进动机,以预防开始,或减少,药物使用和相关的危险行为。与酒精相比,预防吸毒在校园里被忽视,尽管吸毒很普遍,后果很严重。海洛因是使用最广泛的非法药物,其次是处方药的非医疗使用,包括兴奋剂(苯丙胺、哌甲酯)和类阿片(羟考酮、氢可酮)。2003年,大约10%的高中毕业生报告非医疗使用氢可酮,使其成为这一群体中第三大滥用药物,仅次于大麻和安非他明。从2002年到2003年,滥用羟考酮在大学年龄段的年轻人中增加了近40%。将处方药与其他药物(如酒精)混合使用,会进一步增加药物相互作用和过量的风险。大学生容易获得和有效的药物预防的公共卫生需求是明确的。国家药物开发署最近的举措认识到了这一需要(《处方药滥用》,PA-01-110; Claudow,2005年)。MSB药物将使用技术和丰富的媒体来纳入关键的循证预防功能,包括个人风险评估和量身定制的反馈,以促进动机,有关不同药物和成瘾的相关教育,以促进准确的风险评估,以及技能建设活动,以促进拒绝和应对技能和自我效能。第一阶段涉及概念验证研究,以证明产品的可行性。第二阶段将涉及一个全面运作的MSB药物网站的生产和可用性测试,以及一项随机对照试验,以评估影响药物相关知识、态度和行为的计划效力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SARAH E LORD其他文献
SARAH E LORD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SARAH E LORD', 18)}}的其他基金
Mindful Moms in Recovery: Yoga-based mindfulness relapse prevention for pregnant women with opioid disorder
康复中的正念妈妈:基于瑜伽的正念预防患有阿片类药物障碍的孕妇复发
- 批准号:
10020323 - 财政年份:2018
- 资助金额:
$ 46.84万 - 项目类别:
Feasibility of online parent training to promote parent-adolescent communication
在线家长培训促进亲子沟通的可行性
- 批准号:
7642609 - 财政年份:2009
- 资助金额:
$ 46.84万 - 项目类别:
Next Edition: Mulitmedia Adolescent Drug Prevention
下一版:多媒体青少年毒品预防
- 批准号:
6443685 - 财政年份:2001
- 资助金额:
$ 46.84万 - 项目类别:
Multimedia Addiction Severity Index for Adolescents
青少年多媒体成瘾严重程度指数
- 批准号:
6693448 - 财政年份:2001
- 资助金额:
$ 46.84万 - 项目类别:
Multimedia Addiction Severity Index for Adolescents
青少年多媒体成瘾严重程度指数
- 批准号:
6801569 - 财政年份:2001
- 资助金额:
$ 46.84万 - 项目类别:
Multimedia Addiction Severity Index for Adolescents
青少年多媒体成瘾严重程度指数
- 批准号:
6337859 - 财政年份:2001
- 资助金额:
$ 46.84万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 46.84万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 46.84万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 46.84万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 46.84万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 46.84万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 46.84万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 46.84万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 46.84万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 46.84万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 46.84万 - 项目类别:














{{item.name}}会员




